ML314 is primarily recognized for its role in scientific research, particularly in the study of neurodegenerative diseases. It functions as a potent and selective inhibitor of the Nrf2 pathway, which is implicated in cellular defense mechanisms against oxidative stress. Researchers utilize ML314 to investigate the molecular mechanisms underlying conditions such as Parkinson's disease, where oxidative stress plays a significant role. By inhibiting Nrf2, ML314 helps to elucidate the pathway's contribution to disease progression and potential therapeutic targets. Additionally, it serves as a valuable tool in pharmacological studies aimed at developing novel treatments for oxidative stress-related disorders. Its application is largely confined to laboratory settings, where it aids in advancing understanding of cellular responses to oxidative damage.